Aspect Biosystems Ltd.

16 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Jun 2032

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Feb 15 to 28, 2027 · next Feb 15
2 fees due Mar 5, 2027
1 fee due May 26, 2027
The maintenance fee for Efficient Induction of Definitive Endoderm from Pluripotent Stem Cells (US 10,487,313) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,487,313	Efficient Induction of Definitive Endoderm from Pluripotent Stem Cells In force Term ends Jun 21, 2032 · High confidence	In force	Term ends Jun 21, 2032	High confidence
US 10,221,392	Generation of Pancreatic Endoderm from Pluripotent Stem Cells using Small Molecules In force Term ends Sep 3, 2033 · High confidence	In force	Term ends Sep 3, 2033	High confidence
US 11,738,501	System For Additive Manufacturing Of Three-Dimensional Structures And Method For Same In force Term ends Jun 13, 2034 · High confidence	In force	Term ends Jun 13, 2034	High confidence
US 12,441,050	System for Additive Manufacturing of Three-Dimensional Structures and Method for Same In force Term ends Jun 13, 2034 · High confidence	In force	Term ends Jun 13, 2034	High confidence
US 11,046,930	System For Additive Manufacturing Of Three-Dimensional Structures And Method For Same In force Term ends Apr 11, 2035 · High confidence	In force	Term ends Apr 11, 2035	High confidence
US 11,746,333	Continuously Bioprinted Multilayer Tissue Structure In force Term ends Jun 16, 2036 · High confidence	In force	Term ends Jun 16, 2036	High confidence
US 12,553,035	Continuously Bioprinted Multilayer Tissue Structure In force Term ends Jun 16, 2036 · Low confidence	In force	Term ends Jun 16, 2036	Low confidence
US 12,280,178	Bioprinted meniscus implant and methods of using same In force Term ends Jun 16, 2037 · From the USPTO record	In force	Term ends Jun 16, 2037	From the USPTO record
US 11,744,919	Bioprinted meniscus implant and methods of using same In force Term ends Oct 22, 2037 · From the USPTO record	In force	Term ends Oct 22, 2037	From the USPTO record
US 11,274,280	Generation of Functional Beta Cells From Human Pluripotent Stem Cell-Derived Endocrine Progenitors In force Term ends Mar 18, 2038 · High confidence	In force	Term ends Mar 18, 2038	High confidence

10 of 16 patents shown.

Pro members see all 16.

Pro members: see all 16 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 no status recorded

List them